"far more superior than first line FDA drugs in a 4 billion dollar market"
In test tubes and rats! Benny Buns, there are hundreds of preclinical assets that are superior to FDA drugs.... in rats.
Most of them don't require adjunct cheese therapy too.
- Forums
- ASX - By Stock
- NYR
- Ann: Investor Presentation
NYR
nyrada inc.
Add to My Watchlist
10.0%
!
22.5¢

Ann: Investor Presentation, page-115
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.5¢ |
Change
-0.025(10.0%) |
Mkt cap ! $47.45M |
Open | High | Low | Value | Volume |
25.0¢ | 25.0¢ | 22.5¢ | $209.3K | 892.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7150 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 416666 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 157420 | 0.220 |
2 | 120005 | 0.215 |
4 | 170000 | 0.210 |
1 | 30000 | 0.205 |
3 | 119346 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 416666 | 1 |
0.245 | 5000 | 1 |
0.250 | 38461 | 1 |
0.255 | 25000 | 1 |
0.260 | 54498 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online